US FDA advisers to discuss Pfizer's maternal RSV vaccine : v

Advisers to the U.S. Food and Drug Administration on Thursday will discuss Pfizer Inc's experimental respiratory syncytial virus vaccine intended to protect infants through six months of age when... | May 18, 2023

Related Keywords

Bengaluru , Karnataka , India , United States , Raghav Mahobe , Barney Graham , Pfizer , European Commission , Morehouse School Of Medicine , Us Centers For Disease , Astrazeneca , Morehouse School , Disease Control , Mariam Sunny , Bill Berkrot , Nc Stock Exchange , News , Information , Press Release , Advisers , O , The , Wood , End , Drug , Administration , N , Hursday , Hill , Iscuss , Experimental , Espiratory , Syncytial , Virus , Vaccine , Ntended , Rotect , Infants , Through , Six , Months , F , Ge Pfe Us7170811035 ,